These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 977795)

  • 61. Biological availability of digoxin from Lanoxin produced in the United Kingdom.
    Johnson BF; Fowle AS; Lader S; Fox J; Munro-Faure AD
    Br Med J; 1973 Nov; 4(5888):323-6. PubMed ID: 4758424
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical problems associated with the variable biologic availability of digoxin.
    Shaw TR
    Am Heart J; 1974 Mar; 87(3):399-401. PubMed ID: 4812378
    [No Abstract]   [Full Text] [Related]  

  • 63. Trade names or approved names. Part III. Special cases. Clinical trials.
    Garnham JC
    Postgrad Med J; 1974 Feb; 50(580):114-20. PubMed ID: 4465771
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Evaluation of the physiological availability of drug substances in capsules].
    Mikhaĭlova GS
    Farmatsiia; 1975; 24(1):78-82. PubMed ID: 770209
    [No Abstract]   [Full Text] [Related]  

  • 65. Bioavailability of digoxin tablets.
    Lindenbaum J
    Pharmacol Rev; 1973 Jun; 25(2):229-37. PubMed ID: 4581042
    [No Abstract]   [Full Text] [Related]  

  • 66. [Bioavailability, proof of efficacy and their consequences for drug legislation (author's transl)].
    Schnieders B
    Arzneimittelforschung; 1976; 26(1A):158-63. PubMed ID: 947195
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Therapeutic non-equivalence.
    Br Med J; 1972 Sep; 3(5827):599-600. PubMed ID: 5071688
    [No Abstract]   [Full Text] [Related]  

  • 68. An overview of the analysis and interpretation of bioavailability studies in man.
    Wagner JG
    Pharmacology; 1972; 8(1):102-17. PubMed ID: 4644642
    [No Abstract]   [Full Text] [Related]  

  • 69. Proceedings: Bio availability of digoxin and derivatives.
    Rietbrock N; Guggenmos J
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R80. PubMed ID: 4276634
    [No Abstract]   [Full Text] [Related]  

  • 70. [The biological availability of several digoxin preparations used in the Netherlands].
    Dunning AJ; Buurke EJ; Roos JC; Paalman AC; van Rooy HH
    Ned Tijdschr Geneeskd; 1973 Dec; 117(48):1809-16. PubMed ID: 4788673
    [No Abstract]   [Full Text] [Related]  

  • 71. [Biopharmaceutical classification system--experimental model of the prediction of drug bioavailability].
    Golovenko NIa; Borisiuk IIu
    Biomed Khim; 2008; 54(4):392-407. PubMed ID: 18988456
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Bioavailability].
    Mattila M
    Duodecim; 1973; 89(11):803-5. PubMed ID: 4758891
    [No Abstract]   [Full Text] [Related]  

  • 73. Trade names or approved names. Point II. Points of view. The clinical pharmacologist.
    Turner P
    Postgrad Med J; 1974 Feb; 50(580):93-5. PubMed ID: 4465784
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Criteria for considering equivalence.
    Bicket WJ
    J Am Pharm Assoc; 1973 Jan; 13(1):33-4. PubMed ID: 4682576
    [No Abstract]   [Full Text] [Related]  

  • 75. Drug bioequivalence. Recommendations from the Drug Bioequivalence Study Panel to the Office of Technology Assessment, Congress of the United States.
    J Pharmacokinet Biopharm; 1974 Oct; 2(5):433-66. PubMed ID: 4452945
    [No Abstract]   [Full Text] [Related]  

  • 76. [Equivalency of drugs and the problem of biological availability].
    Hirtz J
    Rev Prat; 1973 Nov; 23(53):7-10. PubMed ID: 4802222
    [No Abstract]   [Full Text] [Related]  

  • 77. Bioavailability of digoxin tablets.
    Steiness E; Christensen V; Johansen H
    Clin Pharmacol Ther; 1973; 14(6):949-54. PubMed ID: 4584152
    [No Abstract]   [Full Text] [Related]  

  • 78. Doctors are pivotal to prescription struggle.
    Chapman S
    Leg Aspects Med Pract; 1979 Mar; 7(3):42-4. PubMed ID: 423688
    [No Abstract]   [Full Text] [Related]  

  • 79. [Biopharmaceutical characteristics of digoxin tablets].
    Avico U; Signoretti Ciranni E; Zuccaro P; Cingolani E; Foschi F; Paciaroni E
    Boll Chim Farm; 1976 Jun; 115(6):432-9. PubMed ID: 1008948
    [No Abstract]   [Full Text] [Related]  

  • 80. Evaluation of digoxin bioavailability in single-dose studies.
    Greenblatt DJ; Duhme DW; Koch-Weser J; Smith TW
    N Engl J Med; 1973 Sep; 289(13):651-4. PubMed ID: 4727968
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.